EndoChoice® to Present at Investor Conferences in November 2015

ALPHARETTA, Ga., Oct. 22, 2015 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today that Mark Gilreath, Founder and Chief Executive Officer, and David Gill, Chief Financial Officer are scheduled to participate in three investor conferences in November 2015.

Event: Brean Capital Life Sciences Summit 
Format: One-on-One Meetings Only
Where:   Millennium Broadway Hotel, New York, NY
Date: Monday, November 16, 2015

Event: Stifel Healthcare Conference
Format: Presentation and One-on-One Meetings
Date: Tuesday, November 17, 2015
Where:   New York Palace Hotel, New York, NY
Time: 8:00 a.m. ET

Event: Canaccord Medical Technology & Diagnostics Forum
Format: Presentation and One-on-One Meetings
Date: Thursday, November 19, 2015 
Where:   Westin New York Grand Central, New York, NY
Time: 8:00 a.m. ET

Audio webcasts of the Company's presentations will be available by visiting the investor relations section of EndoChoice's web site at www.endochoice.com. Replays of the presentations will be available for 90 days.

About EndoChoice:

Based near Atlanta, Georgia, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®). EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

Company Contact:

David Gill, Chief Financial Officer
678-585-1040 
[email protected]  

Investor Contacts:

Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
[email protected]
[email protected]

SOURCE EndoChoice Holdings, Inc.

Related Links

http://www.endochoice.com